Embryos express paternal antigens that are foreign to the mother, but the mother provides a special immune milieu at the fetal-maternal interface to permit rather than reject the embryo growth in the uterus until parturition by establishing precise crosstalk between the mother and the fetus. There are unanswered questions in the maintenance of pregnancy, including the poorly understood phenomenon of maternal tolerance to the allogeneic conceptus, and the remarkable biological roles of placental trophoblasts that invade the uterine wall. Chemokines are multifunctional molecules initially described as having a role in leukocyte trafficking and later found to participate in developmental processes such as differentiation and directed migration. It is increasingly evident that the gestational uterine microenvironment is characterized, at least in part, by the differential expression and secretion of chemokines that induce selective trafficking of leukocyte subsets to the maternal-fetal interface and regulate multiple events that are closely associated with normal pregnancy. Here, we review the expression and function of chemokines and their receptors at the maternal-fetal interface, with a special focus on chemokine as a key component in trophoblast invasiveness and placental angiogenesis, recruitment and instruction of immune cells so as to form a fetus-supporting milieu during pregnancy. The chemokine network is also involved in pregnancy complications.
INTRODUCTION
The intimate association between maternal and placental tissues elicits an interesting immunological paradox. Placental tissue contains paternal antigens, but under normal circumstances, the allogeneic fetus and placenta are not attacked by the maternal immune system. Interestingly, this tolerance to fetal antigens occurs in the presence of a large number of maternal leukocytes, almost all of which are members of the innate immune system. There is a delicate crosstalk and collaboration between fetus-derived trophoblast cells and maternally-derived cells during normal pregnancy to establish a unique maternalfetal immune milieu that contributes to embryo survival and development in the uterus until parturition. Dysfunction in the interactions of trophoblasts and maternally-derived cells and dysregulation of maternal-fetal immune tolerance are highly linked to some pregnancy failures, such as miscarriage, preeclampsia, fetal growth restriction and so on. The chemokine/chemokine receptor interactions play roles in almost all facets of maternal-fetal crosstalk. In this review, we highlight the contribution of chemokines and their receptors at the maternal-fetal interface to the maintenance of normal pregnancy, especially to maternal-fetal tolerance and to placentation. Since normal pregnancy is a model of natural immune tolerance, pregnancy research may assist in the broader understanding of tumor immunology and of transplantation immunology.
receptors have been identified. 1, 2 Chemokines exert their effects through G protein-coupled receptors. 2 Based on their structural motif, including the number and position of two conserved cysteine residues, chemokines are classified into subfamilies: the CXC, CC, CX3C and C groups or the a, b, c and d subfamilies. Chemokine receptors are also divided into four corresponding groups. 3 One or three amino acids separate the first and second cysteines in the CXC and CX3C chemokines, respectively, the two cysteines are adjoining in the CC subfamily, and the C subfamily lacks the first and pairing third conserved cystein residues. The fifth receptor subfamily, CX, reported only in zebrafish lacks the two N-terminal residues, but retains the third and fourth residues. 4 The CXC family can be further subdivided by the presence or absence of a conserved 'Glu-Leu-Arg' (ELR) subsequence at the NH2 terminus. The ELR 1 family is involved in angiogenesis and the ELR 2 family is involved in angiostatic activity. 5 The primary functions of chemokines are the directional stimulation of immune-cell adhesion and migration into the infected or inflamed tissue to initiate effective immune responses. However, chemokine functions are not restricted to chemotaxis but serve many other immune purposes such as dendritic cell (DC) maturation, 6 B-cell antibody class switching, 7 and T-cell activation and differentiation. 8 Chemokines are also potent mediators of neoangiogenesis and tumor growth, invasion, and metastasis, 9, 10 and play a pivotal role in embryogenesis and organ transplantation.
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More recently, chemokine receptors with structural features that are inconsistent with a signalling function have been described. When ligated, these 'silent' (non-signalling) chemokine receptors do not elicit migration or conventional signalling responses, but regulate inflammatory and immune reactions in different ways, such as acting as decoys or scavengers. The availability of chemokines is regulated by three non-signalling decoy receptors: chemokine decoy receptor (D6), Duffy antigen receptor for chemokines (DARC) and chemocentryx decoy receptor (CCX CKR). The expression of decoy receptors is mainly restricted in placental cells and endothelial cells of lymphatic afferent vessels in skin, gut and lung. [12] [13] [14] THE CHEMOKINE NETWORK AT THE MATERNAL-FETAL INTERFACE After the blastocyst hatches from the zona pellucida and adheres to the endometrium during the onset of the implantation window, trophoblast cells proliferate and differentiate into cytotrophoblast and syncytiotrophoblast, resulting in the formation of anchoring chorionic villous. Highly invasive cytotrophoblasts invade into the luminal epithelium and subsequently the myometrial stroma as interstitial trophoblast, which then migrate and infiltrate the endothelium, and remodel the maternal spiral arteries. At the maternal side is located by decidual cells including around 70% of decidual stromal cells (DSCs) and the infiltrated dedual immune cells (DICs) at the site of implantation. The DICs are comprised of natural killer (NK) cells (70%), macrophages (15%), T (15%) cells and very little of other types of immune cells. Thus, fetal trophoblasts, maternal DSCs and DICs are the main components at the maternal-fetal interface. Figure 1 describes the dynamic formation process of maternal-fetal interface in early human pregnancy. Functional chemokines and their receptors are widely expressed at the maternal-fetal interface, and play a pivotal role in this intercellular communication. Through Reverse Transcription-Polymerase Chain Reaction (RT-PCR) assay, our group systematically analyzed the expression of 18 chemokine receptors at the maternal-fetal interface disclosing general and differential expression patterns. In primary trophoblast, we found high levels of CXCR4 and CXCR6 mRNA, moderate expression of CCR1, CCR3, CCR5, CCR8, CCR9, CXCR1, CXCR4, CXCR6, XCR1 and CX3CR1 and no expression of CCR2, CCR6, CCR7, CCR10 and CXCR5. 15 In contrast, in human DSCs, CCR2, CCR5 and CCRl0 are highly expressed while CCR1, CCR3, CCR4, CCR6, CCR8-9, CXCRl, CXCR4, CXCR6, XCR1 and CX3CRl are moderately expressed. CCL2 and CCLl3, the ligands of CCR2, and CCL28, the ligand of CCRl0, are also expressed highly in decidua and DSCs. 16 Further studies have shown that primary trophoblasts secrete high levels of CXCL12 and CXCL16, while DSCs produce abundant CCL2. [15] [16] [17] In addition, trophoblasts secrete CCL24, whereas DSCs express its receptor, CCR3. 18 These data suggest that a complicated chemokine/chemokine receptor network is present at maternal-fetal interface.
CXCL14 is a relatively newly-identified chemokine with an unidentified receptor and undefined function. CXCL14 is selectively expressed in early villous cytotrophoblasts and DSCs. 19 When villous cytotrophoblasts differentiates into syncytiotrophoblast cells, CCR3 and CCR6 become highly expressed. 20 CCR1 and CCL17 are localized on extravillous cytotrophoblast cells (EVTs). 21, 22 CXCR4 and CXCR7 are expressed during the differentiation process of cytotrophoblasts towards the invasive phenotype, 23 and their ligand CXCL12 is widely expressed in multiple cell types at the maternal-fetal interface. 22 Invasive EVTs express CX3CR1. 24 As for the maternal side of the interface, there is widespread expression of chemokines. On DSCs, these include the ligands CCL2, CCL4, CCL7, CCL14, CCL16, CCL17, CXCL9, CXCL10, CXCL11, CXCL14 and CX3CL1 and the receptors CCR2, CCR3, CCR10, CXCR3 and CXCR4. [25] [26] [27] In addition, CCL2, CCL28 and CX3CL1 are also immunolocalized on the decidual epithelial cells (DECs). 28, 29 CCR3 and CCR4 are expressed on the invading interstitial EVTs. 30, 31 In addition to trophoblasts and DSCs, chemokine receptors are expressed on decidual immune cells. CCR2, CCR5 and CXCR4 are present on most of CD45 1 cell types. CXCR6 localizes on decidual T cells, NK T cells and macrophages, but not on NK cells. 32 Decidual T cells also express CCR4, while most of the NK cells express CXCR3. 22, 33 Decoy receptors (DARC, D6 and CCX CKR) and ligands are expressed at the maternal-fetal interface, especially by invading trophoblast cells and on the apical side of syncytiotrophoblast cells. The dysregulation of decoy receptors often occurs at sites of fetal arrest. 14, 34, 35 Presented in Figure 2 is a summary of the expression of chemokines and their receptors at the maternal-fetal interface in early human pregnancy. 
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iEVT CXCR1 CXCR3 Decoy receptors Figure 2 The expression of chemokines and chemokine receptors at the human maternal-fetal interface in mid to late first trimester. Figure 1 The dynamic process of formation of the maternal-fetal interface in early pregnancy. The embryo arrives at the uterus about 6-7 days after fertilization. At first, the free floating blastocyst is surrounded by its zona pellucida in utero, then the blastocyst hatches from the zona pellucida and adheres to the endometrium during the implantation window. Adhesion induces trophoblast cells to differentiate into inner cytotrophoblast and outer syncytiotrophoblast, resulting in formation of anchoring chorionic villous. Then the syncytiotrophoblast layor is penetrated by proliferative trophoblast cell columns. The columns give rise to highly invasive extravillous trophoblasts that invade into the decidua and subsequently the myometrial stroma as interstitial trophoblast. Interstitial trophoblast can migrate to infiltrate vascular smooth muscle walls and endothelium and remodel the maternal spiral arteries. On the maternal side, decidual stromal cells accounting for 70% of decidual cells, and dedual immune cells including NK (70%) cells, macrophages (15%) and T (15%) cells. About 5 weeks after implantation, the placenta forms from the trophoblast and decidua. So the fetal trophoblasts, maternal decidual stromal cells and decidual immune cells constitute the maternal-fetal interface. DECs, decidual epithelial cells; DICs, decidual immune cells; DSCs, decidual stromal cells; NK, natural killer.
THE ROLE OF CHEMOKINES IN MATERNAL-FETAL CROSSTALK
During pregnancy, the maternal immune system is in direct contact with fetal alloantigens. Reproductive success depends on the ability to remain tolerant to the fetus and to protect it from infection. 36 To achieve this goal, complex molecular dialogues take place at the fetal-maternal interface. Chemokines are multifunctional molecules involved in intercellular communication and signal transduction. They play important physiological and pathological roles not only in the regulation of DIC recruitment and function, but also in embryo implantation and trophoblast invasion.
Enrichment of immune cells in decidua during pregnancy
During decidualization, uterine leukocytes dramatically increase in numbers and account for at least 15% of all cells in the decidua early pregnancy through term. Moreover, they have an unusual composition distinct from blood because the large majority (70%) is CD56 bright CD16
2 NK cells and monocytes (15%), while T cells (10%-15%) represent the minority of the immune cells. The origin of uterine leukocytes remains unclear. One possibility is that they are recruited from peripheral blood and/or other tissues. Because chemokine/chemokine receptor interactions dominate the trafficking of leukocytes, the mechanisms underlying the recruitment and maintenance of DICs most likely involve the expression and secretion of chemokines at the maternal-fetal interface ( Table 1) . 1 NK cell numbers in endometrium. 40, 41 Croy et al. 42 reported that, in contrast to human pregnancy, murine NK cell homing to the decidua was independent of CXCR3 and of additional chemokine receptors, such as CCR2. Decidual cells produce various types of chemokines, such as CCL2, CXCL8, CX3CL1, CXCL10 and CXCL12, at significant levels. These chemokines are differently involved in the migration of peripheral NK (pNK) and decidual NK (dNK) cells into the decidua. 28, 43, 44 Interestingly, CXCL12 and CX3CL1 preferentially attract CD16
Recruitment of NK cells
1 pNK cells, while CXCL10 is essential for the recruitment of CD56 high CD16 2 pNK cells. 33, 45 Uterine expression of CXCL14 may also play a role in uterine NK-cell recruitment during the early pregnancy. 46 However, a clear picture of the effects of CXCL14 on uterine NK-cell recruitment in the context of the uterus is still vague, since a report using knockout models indicates opposite effects of its chemoattractant roles on many types of leukocytes. 47 These studies suggest that NK cells use more than one type of receptor-ligand pairing to enter the uterus, and these chemokines may act sequentially or in combination to contribute to the accumulation of NK cells in the decidual tissues.
Recruitment of antigen-presenting cells (macrophages and DCs)
As initial responders to external pathogens and alloantigens, antigen-presenting cells play a central role in the delicate balance between protective immunity and tolerance. Macrophages are the most abundant antigen-presenting cell in the decidua (DCs only account for 1% of the leukocytes). 48 Microarraybased gene expression analysis indicates that macrophages isolated from decidua during the first trimester adopt an antiinflammatory M2 phenotype, with upregulation of CCL18, CD209 (DC-SIGN), mannose receptor C type-1, fibronectin 1 Table 1 The involvement of chemokine and chemokine receptor signaling in the recruitment of decidual immune cell subtypes Mw  CCR1-CCL3, CCL5  CCR2-CCL2  CCR2-CCL2  CXCR1-CXCL8  CXCR6-CXCL16  CXCR3-CXCL10, CXCL11  Th2  CCR4-CCL17  CXCR4-CXCL12  CX3CR1-CX3CL1  DC  CCR1-CCL5  Treg  CCR2-CCL2  CCR2-CCL2  CCR4-CCL17, CCL22  CCR3-CCL7  CCR5-CCL4  CCR5-CCL4  CCR6-CCL20  CCR6-CCL20  CCR7-CCL19  CCR7-CCL21 CXCR4-CXCL12
Abbreviations: DC: dentritic cell; Mw, macrophage; NK, natural killer; Th2: T helper 2 cell; Treg: regulatory T cell.
Roles of chemokine in early pregnancy MR Du et al and insulin-like growth factor-1. 49 CCL2, CCL3 and regulated on activation, normal T-cell expressed and secreted (CCL5) are possible factors involved in the recruitment and functionality of decidual macrophages. [50] [51] [52] It was also shown that trophoblast cells regulate monocyte migration through the production of CCL3 and CCL2. 39, 50 Our previous study has demonstrated that DSC-secreted CCL2 and trophoblast-secreted CXCL16 contribute to the recruitment of peripheral monocyte to the decidua. 32, 53 Furthermore, decidual macrophages secrete high level of CCL2 that recruit additional macrophages into the decidua. 54 DCs are considered to be the immune 'guardians' in the uterine-mucosa, capable of inducing tolerance under normal physiological conditions. 55 DCs in the decidua produce less IL-12 than do peripheral blood DCs, and decidual myeloid DCs induce a higher percentage of T-helper type 2 (Th2) lymphocytes than do peripheral blood DCs.
56 CCL2 and CCL5 secreted by the first trimester decidua are responsible for the accumulation of DCs in the decidua. 57 
Recruitment of T cells Compared with CD56
bright CD16 2 NK cells and macrophages, T cells are less abundant at the maternal-fetal interface, but have been proposed to play an important role in immune regulation. It has long been accepted that T-cell activity at the fetal-maternal interface is skewed toward Th2-like bias, thus contributing to a pregnancy-protecting environment that may be disturbed in recurrent abortions, 37, 58 Recently, more subsets of CD4 1 T cells have been characterized at the maternal-fetal interface. There is a balance between the Th1 and Th2 cells, as well as Th17 and regulatory T cells (Tregs) in the firsttrimester human decidua. 59 Chemokine receptors are differentially expressed on polarized Th cells. Typically, CXCR3 and CCR5 are preferentially expressed on polarized Th1 cells, whereas CCR3, CCR4 and CCR8 are associated with the Th2 phenotype. 60 The possibility that Th2 cells are preferentially recruited by uterine cells through chemokine secretion has been proposed. CCL17, a Th2 chemokine, is produced by trophoblasts and endometrial gland cells, and regulates the infiltration of CCR4 1 T lymphocytes into human decidua during the early pregnancy. 61 Previously, we confirmed that decidual DCs instructed by trophoblasts produce high levels of IL-10 and CCL17, inducing a Th2 bias at the maternal-fetal interface. 62 Aggressive CCR6
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Th1 cells are much less frequent in decidua as compared with blood. 63 CXCL9, the Th1/Tc1-attracting chemokine is silenced in decidua, thus restricting Th1 cell recruitment to the maternal-fetal interface. 64 Tregs have been identified during pregnancy in both humans and mice, and are thought to play a role in maternal immunotolerance. [65] [66] [67] In human pregnancy, CD4 1 CD25 high Tregs localize preferentially to the decidua compared to peripheral blood, constituting approximately 22% and 6.5% of leukocytes, respectively. 68,69 CCL19, a major chemokine generated by glandular and luminal epithelial cells, acts through CCR7 and mediates the recruitment of Tregs from the circulation into the uterus. 70 Expression of CCL2, CCL22, CCL17, CCL4 and CCL20 in the uterus may selectively recruit Tregs from peripheral tissues. [71] [72] [73] Lin et al. 74 have demonstrated that CXCL12 produced by trophoblast enhances exogenous CD4 1 CD25
1 T-cell migration and prevents embryo loss in non-obese diabetic mice. Therefore, through interactions of chemokines and their receptors, the maternal-fetal interface recruits immuneregulatory Th2 and Treg cells, helping to form an immune tolerant microenvironment.
CHEMOKINE INSTRUCTION TO DECIDUAL IMMUNE CELLS
A distinctive immune tolerance-promoting environment develops at the maternal-fetal interface to avoid rejection of the embryo by the maternal immune system. DICs have special features in local cytokine production, downregulation of cytotoxicity and promotion of placental development that pace the progression of a healthy pregnancy. 75 How the distinct DICs develop has received intense attention. Increasing data indicate that the local environment drives them into functionally different subsets. [76] [77] [78] Chemokine may be the key to regulation of DIC function.
NK cells, the dominant immune cell type in the decidua during early pregnancy, are critical in maintaining maternalfetal tolerance and regulating placental vascular remodeling owing to their unique phenotype. 79 Decidual NK cells are recruited from peripheral blood via chemokine/chemokine receptor interactions. Coculture of pNK cells and trophoblast cells results in significant downregulation of CCR1, CCR5, CXCR1, CXCR4 and CX3CR1, while CXCR3 is upregulated. 33 This suggests that pNK cells undergo reprogramming of their chemokine receptor profile once exposed to the uterine microenvironment. Interestingly, the chemokine receptor profile of pNK cells instructed by trophoblast cells closely resembles that of dNK cells. CXCL12 is required for NK development in addition to recruitment, suggesting that the high CXCL12 levels in the decidual environment might contribute to the unique phenotype and function of dNK cells. 80 Our unpublished data indeed demonstrate that trophoblasts instruct NK cell phenotype and function via CXCL12/CXCR4 signalling. Additionally, CCL2 secreted by DSC inhibits NK cells cytotoxicity by upregulation of SOCS3.
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CCL2 and DSC-derived supernatant can promote Th2 cytokine production while inhibiting Th1 cytokines production by DICs, suggesting that DSCs induce a decidual Th2 bias via CCL2 secretion. This modulation may occur by affecting the expression of the Th1/Th2-specific transcription factors T-bet and GATA-3, thus, contributing to the Th2 bias at the maternalfetal interface. Th2 cytokines can also promote CCL2 secretion by DSCs, further promoting this bias in the decidua, 16 ,53 which suggests a positive regulatory loop. Furthermore, CXCL12 produced by trophoblast also contributes to Th2 bias at the maternal-fetal interface. 82 Although the exact mechanism is not known, CXCL12 may associate with signal transducers and activator of transcription-6. 83 , 84 Huang and Fan reported that cdT cells recruited into the decidua via CXCL16/CXCR6 interaction play an important role in the Th2 bias at the maternal-fetal interface and in the development and progression of the placenta by producing high levels of IL-10 and TGF-b. 32, 85 Therefore, trophoblasts and DSCs appear to induce the differentiation of immune cells into an embryo-supporting phenotype.
REGULATION OF CHEMOKINES ON TROPHOBLAST INVASIVENESS AND PLACENTAL ANGIOGENESIS
During human placental development, cytotrophoblasts differentiate to form the syncytium or invade the decidual wall to breach maternal vessels and establish blood flow to the intervillous space. Trophoblast migration within the decidualized endometrium and uterine vasculature is essential for normal placental and fetal development. 86, 87 Chemokines have roles in key aspects of placentation, including cytotrophoblast differentiation, and proliferation, as well as in recruitment of immune cells into the decidua. 88 The placenta is a rich source of CXCL12 and its receptor CXCR4. 89 We found that first-trimester human trophoblasts promote their own invasiveness and matrix metalloproteinase (MMP) activity through co-expression of CXCL12 and CXCR4. 90 Furthermore, CXCL12 promotes the crosstalk between trophoblasts and DSCs in human first-trimester pregnancy. This crosstalk enhances trophoblast invasiveness by amplifying MMP-9 and MMP-2 secretion from trophoblast and DSCs, 90 but also limits overinvasiveness of trophoblasts by upregulating CD82 (tumor metastasis suppressor gene) expression in a paracrine manner.
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CXCL12 promotes human trophoblast proliferation and invasion via epithelial growth factor receptor and extracellular signal regulated kinase activation.
92 CXCL12 can also activate NF-kB, and induce p65 nuclear translocation, 93 inhibiting trophoblast invasion by enhancing transcription of CD82.
CXCL16 secreted by trophoblasts can induce invasive growth of trophoblasts in an autocrine manner. 94 CCR1 is present on the surface of EVTs grown from chorionic villous explants. CCL5 and CCL2, the ligands of CCR1, are expressed by decidual tissue and promote the migration of the EVTs from the explant cultures in vitro. 95 These studies suggest that decidual cells regulate trophoblast invasiveness via interactions of CCR1 and its ligands. Furthermore, decidual epithelial cells promote villous cytotrophoblast survival and EVT migration via production of CXCL8, CXCL10 and CXCL11 that bind to CXCR1 and CXCR3 on trophoblast cells. [96] [97] [98] CCL5 secreted by decidual tissue is a chemoattractant for human invading trophoblasts and blastocysts. However, some chemokines, such as CXCL14 and CXCL6, inhibit trophoblast invasive growth through downregulation of MMP-2 and MMP-9 activity. 19, 99 DECs promote CCL17 expression by decidual macrophage with alternative activation that controls trophoblast invasion induced by NK cells. 100 These results suggest that the chemokine-mediated crosstalk between decidual cells and trophoblasts at the maternal-fetal interface is essential for proper trophoblast invasion and placental development.
During placentation, invasive trophoblasts interact with arteries rather than veins, which has been a mystery for a long time. Recent progress demonstrates that ephrin signaling is critical for the preferential remodeling of arterioles by trophoblasts. This process is mediated through limiting CXCL12-induced migration of arterial endothelial cells into veins. 101 In addition, human endometrial microvascular endothelial cells produce CXCL9 and CXCL10, 102 which stimulate the proliferation of myofibroblast-like renal perivascular cells, and display angiostatic activity through a protein kinase Amediated inhibition of m-calpain. 103, 104 It is postulated that extensive crosstalk between placental trophoblasts and DICs, produces angiogenic factors near maternal spiral arteries. 58 Maternal DICs, especially dNK cells and also DCs, play an important role in the immune regulation of trophoblast invasion and uterine spiral arteries remodeling. 105 Although this process is still not well understood, chemokines and their receptors are likely involved in guiding cytotrophoblasts to the decidua and maternal vessels and in attracting immunocompetent cells to the implantation site by either recruitment of VEGF-expressing macrophages or direct stimulation of chemokine receptors on the endothelium. [106] [107] [108] By producing CXCL8 and CXCL10, dNK cells promote trophoblast invasion toward the spiral arteries via interactions of these chemokines and their receptors, CXCR1 and CXCR3. 109, 110 Decidual CD56 bright CD16 2 NK cells are the main source of IFN-c at the maternal-fetal interface. IFN-c can upregulate the production of CXCL9, CXCL10, CCL8, and CCL5. The release of these cytokines enhances trophoblast invasion and promotes vascular remodeling. Besides IFN-c, uterine NK cells secrete other angiogenic factors, including VEGF, angiopoietin-2 and placental growth factor. [111] [112] [113] DCs are associated with vascular growth during the early gestation. 58, 105 CXCL12/CXCR4 signalling is important in the regulation of decidual angiogenesis by DCs. Blocking CXCR4
1 DC homing during the early gestation results in disorganized decidual vasculature with impaired spiral artery remodeling later in gestation. In mice, adoptive transfer of CXCR4 1 DC promotes adequate remodeling of the spiral arteries in the decidua, thus rescuing early pregnancy. 114 
INVOLVEMENT OF CHEMOKINES IN PREGNANCY COMPLICATIONS
The expression of chemokines and their receptors at the maternal-fetal interface has important implications for understanding the role of chemokines in the regulation of placental growth and development, and in maternal-fetal tolerance. The abnormal expression of chemokines is related to pathological pregnancy, such as miscarriage, pre-eclampsia and preterm labour.
Miscarriage is the most common complication of pregnancy. One well-accepted cause of miscarriage is related to an abnormal shift towards the Th1 type response. CXCR3 and CCR5 are expressed preferentially on Th1-type cells, while CCR3 and CCR4 are expressed on Th2-type cells. 60 In a mouse model of miscarriage, CCR3 expression on peripheral blood CD4 1 T cells is significantly decreased, while the expression of CCR5 and CXCR3 is markedly increased. This is also observed in humans. Furthermore, paternal leukocyte immunization of women who have experienced three or more spontaneous abortions increased levels of Th2-related CCR4 expression on CD4
1 T cells and improved pregnancy outcome. 115 Fetal loss in animals and humans is frequently associated with inflammatory conditions. D6 is a promiscuous chemokine receptor with a decoy function that degrades most inflammatory CC chemokines. 116 Treatment of D6-deficient pregnant mice with LPS or antiphospholipid autoantibody results in fetal loss with higher levels of inflammatory CC chemokines and increased leukocyte infiltrate in the placenta. Interestingly, blocking inflammatory chemokines rescues the fetal loss. 35 These results indicate a critical role of D6 in the protection from fetal loss induced by systemic inflammation and antiphospholipid antibodies.
Pre-eclampsia affects at least 5% of pregnancies globally and is a leading cause of both maternal and perinatal morbidity and mortality, even in developed countries. 117 The expression of CCL2 and CCL5 is increased in pre-eclampsia as is CCL2 and CCL5 expression by first-trimester decidual cells may account for the accumulation of macrophages and DCs in pre-eclamptic decidua. 52, 57 Serum levels of CXCL10 and CXCL8 are also elevated during pre-eclampsia compared with healthy pregnancies, resulting in an overall pro-inflammatory systemic environment. 118, 119 Increased CXCL10 and CCL2 concentrations in pre-eclamptic patients significantly correlate with blood pressure values, and renal and liver function parameters. 52 These chemokines and their underlying signaling molecules are potential diagnostic and therapeutic targets for pre-eclampsia management.
Appreciating changes in chemokine expression helps our understanding of their roles during the inflammatory response that is associated with spontaneous preterm labour. The search for markers of preterm labour has identified increased expression of CXCL8 in cervical mucus, and CCL2 and MIF in maternal serum or amniotic fluid. [120] [121] [122] The presence of CCL8, CCL5, CCL20, CXCL5 and CCL7 in amniotic fluid is associated with microbial invasion and amniotic cavity inflammation during preterm labour. [123] [124] [125] [126] CXCL11 level is increased in amniotic fluid during second trimester in women who subsequently developed preterm labour. 127 Increased levels of the CCR6 ligand CCL20 in amniotic fluid was associated with prematurity. 128 Elevated CXCL10 puts patients at risk for spontaneous preterm delivery after 32 weeks of gestation. 129 As discussed above, chemokines are involved in pregnancy complications, and some are key players in pathological conditions. Therefore, chemokine/chemokine receptor interactions should be targeted as a therapeutic option to treat specific pregnancy complications. For example, the pattern of CXCR4 (specific receptor for CXCL12) expression on peripheral blood NK cells was analyzed and NK-cell migration was demonstrated in vitro and in vivo by migratory assays. Furthermore, CXCL12 is produced by murine trophoblast cells and the recruitment of peripheral CXCR4-expressing ITGA2CISG20C NK cells into pregnant uteri can prevent embryo loss in non-obese diabetic mice. 130 However, whether this is clinically relevant still requires further investigation.
Though we previously stated that an anti-inflammatory microenvironment is necessary for a successful pregnancy, additional studies report that local injury of the endometrium triggers an inflammatory response characterized by an influx of macrophages/DCs and increased expression of pro-inflammatory cytokines that actually facilitates successful implantation in patients using assisted reproductive technologies. 131, 132 In a controlled clinical study, analysis of cytokines in endometrial samples recovered from the biopsy-treated patients revealed increased CCL4 expression, which in turn recruits macrophages/DCs to the site of implantation. The abundance of these cells and the expression of proinflammatory cytokines positively correlate with pregnancy outcomes. 133 The increased CCL4 expression could possibly serve as a predictor of implantation competence and may also be used to clinically predict pregnancy outcomes.
CONCLUSIONS
Successful pregnancy requires an optimal interaction between maternal and fetal cells for mutual tolerance and prevention of excessive inflammation. The mammalian fetus has been perceived, paradoxically, as a successful allograft, successful tumor, or a successful parasite. Local suppression of maternal immune responses at the maternal-fetal interface is necessary, Figure 3 Regulation of maternal-fetal tolerance and placental development via chemokine/chemokine receptor interactions. The interaction of trophoblast-derived CXCL12 with CXCR4 promotes trophoblast invasiveness in an autocrine manner, and prevents excessive trophoblast invasion by enhancing CD82 expression on DSCs in a paracrine manner. Additionally, CXCL12 recruit and instruct NK cells. Trophoblastderived CXCL16 and DSC-derived CCL2 bind to CXCR6 1 T cells and CCR2 1 T cells, respectively, contributing to decidual T-cell accumulation and Th2 bias at the maternal-fetal interface. Trophoblasts actively secrete TSLP inducing a classic Th2 bias at the maternal-fetal interface by instructing decidual DCs to produce high levels of CCL17. ": upregulation; #: downregulation. DSC: decidual stromal cell; dNK, decidual natural killer; Tros, trophoblasts; TSLP, thymic stromal lymphopoietin.
while systemic immune reactions to allogeneic tissue or infection must remain undisturbed. Chemokines regulate multiple events that are closely associated with normal pregnancy including fetal protection and placental development by modulation of homeostasis and functions of immune and trophoblast cells in a paracrine or autocrine manner (Figure 3 ). Chemokines also participate in many pathological conditions, and are poised in a central switchboard position when immune surveillance and reciprocal tolerance are needed. Our understanding of how the chemokine-chemokine receptor network orchestrates crucial events during normal pregnancy, as well as during pregnancy complications, remains incomplete. Nevertheless, recent advances in molecular biology have dramatically enhanced our knowledge of the immunobiology of the maternal-fetal interface. Further research in these areas will give us more avenues for preventing pregnancy complication related to deficient trophoblast biological function and faulty maternal-fetal immune interactions.
